Tousignant Jennifer
Chief Legal Officer
SaleAlert
- Shares
- 10,000
- Price
- $24.50
- Value
- $245,000
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•22 filings
VRDN
Viridian Therapeutics, Inc.\DE
Net sales of $348.2K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$348,194
0 buyers · 1 sellers
12-month purchases
$19,999,990
3 distinct insiders
12-month sales
$418,990
1 distinct insiders
Highlighted alerts
5
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get VRDN insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
VRDN overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
41
Raw transactions
Everything returned by the filing
5
Voluntary view
P/S trades after deterministic checks
36
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 10,000
- Price
- $14.41
- Footnotes
- 2
The shares sold include 718 shares previously acquired by the reporting person pursuant to the Viridian Therapeutics, Inc. Employee Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). The option was granted on March 3, 2025 and vests in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Tousignant Jennifer
Chief Legal Officer
SaleAlert
- Shares
- 4,212
- Price
- $24.50
- Value
- $103,194
Fairmount Funds Management LLC
Director
PurchaseAlert
- Shares
- 1,176,470
- Price
- $17.00
- Value
- $19,999,990
Tousignant Jennifer
Chief Legal Officer
SaleAlert
- Shares
- 2,272
- Price
- $31.16
- Value
- $70,796
Fairmount Funds Management LLC
Director
PurchaseAlert
- Shares
- 454,545
- Price
- $22.00
- Value
- $9,999,990
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Tousignant Jennifer Chief Legal Officer | Sale | 10,000 | $24.50 | $245,000 | |
| Aug 19, 2026 | Tousignant Jennifer Chief Legal Officer | Sale | 4,212 | $24.50 | $103,194 | |
| May 11, 2026 | Fairmount Funds Management LLC Director | Purchase | 1,176,470 | $17.00 | $19,999,990 | |
| Dec 31, 2025 | Tousignant Jennifer Chief Legal Officer | Sale | 2,272 | $31.16 | $70,796 | |
| Oct 23, 2025 | Fairmount Funds Management LLC Director | Purchase | 454,545 | $22.00 | $9,999,990 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.